The PAUSE Study – A Clinical Trial for People with Psoriasis
PAUSE is a clinical trial testing the effectiveness of ustekinumab (STELARA®) followed by an investigational drug, abatacept, for the treatment of psoriasis. If you are between the ages of 18-65 and have been diagnosed with psoriasis for 6 months or longer, you may be eligible to participate.
PAUSE is being conducted by the Immune Tolerance Network and sponsored by the National Institute of Allergy and Infectious Diseases (NIH funded). For more information, visit www.pausestudy.org.
Видео The PAUSE Study – A Clinical Trial for People with Psoriasis канала ImmuneTolerance
PAUSE is being conducted by the Immune Tolerance Network and sponsored by the National Institute of Allergy and Infectious Diseases (NIH funded). For more information, visit www.pausestudy.org.
Видео The PAUSE Study – A Clinical Trial for People with Psoriasis канала ImmuneTolerance
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
ITN SOP Demonstration: Urine Processing for Single Cell Analysis and ProteomicsGRADUATE - A Clinical Trial Exploring Long-Term Protection from Seasonal Hay FeverThe CALIBRATE study - A clinical trial for people with lupus nephritisLabvantage Supply Order DemoRadio Pet Lady Interviews Jonathan Corren, MD (Cat Chat)Preparation of Platelet-Poor Plasma from Sodium Citrate TubesRadio Pet Lady Interviews Jerry Nepom, MD, PhD (Cat Chat)TrialShare Finder TutorialThe EXTEND Study - A Clincal Trial for People Newly Diagnosed with Type 1 DiabetesITN SOP Demonstration: PBMC Isolation from peripheral blood using SepMate tubesAbout PsoriasisWhat is Immune Tolerance?TrialShare Data and Reports